Myofunctional Therapy in Facial Palsy
Facial Paralysis
About this trial
This is an interventional treatment trial for Facial Paralysis focused on measuring facial paralysis, asymmetry, myofunctional therapy, botulinum toxin, facial evaluation
Eligibility Criteria
Inclusion Criteria:
- facial paralysis with more than 2 years elapsed since the onset of symptoms
- surgically treated for reanimation at least 12 months before
- static and/or dynamic facial asymmetry causing aesthetic concern
Exclusion Criteria:
- spastic paralysis
- serious systemic or neuromuscular diseases
- cognition impairment
- pregnant women
Sites / Locations
- University of Sao Paulo General Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
A: myofunctional prior to botulinum
B: myofunctional after botulinum
All the facial paralysis patients received treatment with botulinum toxin type A to the non-paralyzed side, according to the Institution Protocol. To the participants of Group A, botulinum toxin was applied after myofunctional therapy.
All the facial paralysis patients received treatment with botulinum toxin type A to the non-paralyzed side, according to the Institution Protocol. To the participants of Group B, botulinum toxin was applied before myofunctional therapy.